Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-28 Tax Withholding | 2024-03-01 5:50 pm | N/A N/A | AbbVie Inc. | ABBV | Hudson Thomas J SVP, CSO, GLOBAL RESEARCH | 20,634 | $178.99 | 107,267 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-20 5:15 pm | 2025-02-15 2034-02-14 | AbbVie Inc. | ABBV | Hudson Thomas J SVP, CSO, GLOBAL RESEARCH | 65,484 | $0 | 146,813 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-02 4:35 pm | N/A N/A | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D AND CSO | 27,922 | $154.28 | 81,329 (Direct) | View |
| 2023-02-16 Option Award | 2023-02-21 6:07 pm | 2024-02-16 2033-02-15 | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D AND CSO | 83,279 | $0 | 129,507 (Direct) | View |
| 2022-02-25 Tax Withholding | 2022-03-01 6:09 pm | N/A N/A | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D and CSO | 13,408 | $149.54 | 46,228 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 5:33 pm | 2023-02-17 2032-02-16 | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D and CSO | 55,658 | $0 | 85,030 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 8:29 pm | N/A N/A | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D and CSO | 7,740 | $107.74 | 29,372 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 6:17 pm | 2022-02-18 2031-02-17 | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D and CSO | 54,736 | $0 | 74,379 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 4:54 pm | N/A N/A | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D and CSO | 5,477 | $85.42 | 19,643 (Direct) | View |
| 2020-02-20 Option Award | 2020-02-24 6:02 pm | 2021-02-20 2030-02-19 | AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D and CSO | 74,565 | $0 | 87,313 (Direct) | View |